Eye on publications

SAXS helps to show the effect of an environmentally benign antibiotic on mammalian and bacterial cell walls

Eye on publications

Lab-based SEC-SAXS in combination with several other techniques elucidates the quaternary structure of PieE, an enzyme involved in antibiotic biosynthesis

Covid-19 – Letter from Xenocs Management

By Xenocs CEO Peter Høghøj and Managing Director Frédéric Bossan

Xenocs Inc opens US-West Branch in Calif

Xenocs Inc is pleased to announce the opening of our new branch office in Santa Barbara, California.

SAXSLAB US Inc is now Xenocs Inc

SAXSLAB US Inc will operate as Xenocs Inc, starting January 1, 2020, completing the integration of SAXSLAB US into the worldwide Xenocs group (Grenoble, France).

News from the field

By Eric Danger, Customer Support Engineer at Xenocs.